Cyclosporine A-induced oxidative stress in rat hepatocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 3, 1997, Pages 1328-1334

  Wolf, Armin ^a,c   Trendelenburg, Christian F ^a   Diez Fernandez, Carmen ^a   Prieto, Pilar ^a   Houy, Simone ^a   Trommer, Wolfgang E ^b   Corder, André ^a  

^a Sandoz Pharma Ltd   (Switzerland)

^b Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CYCLOSPORIN A; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE DISULFIDE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; ENZYME ACTIVITY; ENZYME RELEASE; GLUTATHIONE METABOLISM; IMMUNOTHERAPY; LIVER CELL; MALE; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CYCLOSPORINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 0030989834     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. AHMED, S. S., STROBEL, H. W., NAPOLI, K. L. AND GREVEL, J.: Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporin A and FK-506 in rat and human liver microsomes. J. Pharmacol. Exp. Ther. 265: 1047-1054, 1993.
2. AMES, B. N., SHIGENAGA, M. K. AND HAGEN, T. M.: Oxidants, antioxidants, and the degenerative diseases page of aging. Proc. Natl. Acad. Sci. U.S.A. 90: 7915-7922, 1993.
3. AZAIS, V., RACHMAN, F., GROS, S., PASCAL, G. AND AMEDEE-MANESME, O.: Cyclosporine administration decreases liver vitamin A stores in normal and vitamin A-deficient rats. Drug Nutr. Interact. 5: 81-88, 1987.
4. BAKER, M. A., CERNIGLIA, G. J. AND ZAMAN, A.: Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190: 360-365, 1990.
5. BOELSTERLI, U. A., WOLF, A., AND GÖLDLIN, C.: Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat Hepatocytes. Hepatology. 18: 1154-1161, 1993.
6. R). In The Search of AntiInflammatory Drugs, ed. by V. J. Merluzzi and J. Adams, pp. 27-63, Birkhäuser, Boston, 1995.
7. BOREL, J. F., BAUMANN, G., CHAPMAN, I., DONATSCH, P., FAHR, A., MUELLER, E. A. AND VIGOURET, J. M.: In vivo Pharmacological effects of ciclosporin and some analogues, Adv. Pharmacol. 35: 115-246, 1996.
8. BRADFORD M. A.: Rapid and sensitive method for the quantification of microgram amounts of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
9. CARY, N. C.: SAS/STAT User's Guide. SAS Institute Inc. Version 6, 4th ed., vol. 2, 1989.
10. CHANCERELLE, Y., DE LORGERIL, M., VIRET. R., CHIRON, B., DUREAU, G., RENAUD, S. AND KERGONOU, J. F.: Increased lipid peroxidation in cyclosporine-treated heart transplant recipients. Am. J. Cardiol. 68: 813-816, 1991.
11. COMPORTI, M.: Lipid peroxidation, an overview. In Free Radicals: From Basic Science to Medicine, ed. by G. Poli, E. Albano, and M. U. Dianzani, pp.65-79, Birkhäuser Verlag, Basel, 1993.
12. DONATSCH, P., MASON, J., RICHARDSON, B. P. AND RYFFEL, B.: Toxicologic evaluation of the new cyclosporin derivative, SDZ IMM 125, in a comparative, subchronic toxicity study in rats. Transplant. Proc. 24: suppl. 2, 39-42, 1992.
13. DUNNETT, C. W.: A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50: 1096-1121, 1955.
14. DUNNETT, C. W.: Pairwise multiple comparisons in the homogeneous variance, unequal sample size case. J. Am. Stat. Assoc. 75: 789-795, 1980.
15. DURUIBLE, V. A., OKONMAH, A. AND BLYDEN, G. T.: Effect of cyclosporin on rat liver and kidney glutathione content. Pharmacology 39: 205-212, 1989.
16. FARISS, M. W.: Oxygen toxicity: Unique cytoprotective properties of vitamin E succinate in hepatocytes. Free Radical Biol. Med. 9: 333-343, 1990.
17. FRENKEL, K. AND GLEICHAUF, C.: Hydrogen peroxide formation by cells treated with a tumor promoter. Free Radical Res. Commun. 12-13: 783-794, 1991.
18. HALLIWELL, B. AND GUTTERIDGE, J. M. C.: Role of free radicals and catalytical metal ions in human disease: An overview. Methods Enzymol. 186: 1-85, 1990.
19. HISSIN, P. AND HILF, R.: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74: 214-226, 1976.
20. INSELMANN, G., HANNEMANN. J. AND BAUMANN, K.: Cyclosporine A induced lipid peroxidation and influence on glucose-6-phosphatase in rat hepatic and renal microsomes. Res. Commun. Chem. Pathol. Pharmacol. 68: 189-203, 1990.
21. JANSSEN, Y. M. W., VAN HOUTEN, B., BORM, P. J. A. AND MOSSMAN, B. T.: Biology of disease: cell and tissue responses to oxidative damage. Lab. Invest. 69: 261-274, 1993.
22. JONES, D. P. AND KENNEDY, F. G.: Functions of glutathione peroxidase on decomposition of hydrogen peroxide in liver and heart cells. In Functions of Glutathione: Biochemical, Physiological, Toxicological, and Clinical Aspects, ed. by A. Larsson, S. Orrenius, A. Holmgren and B. Mannervik, pp. 109-116, Raven Press, New York, 1989.
23. KAHAN, B. D.: Immunosuppressive therapy. Curr. Opin. Immunol. 4: 553-560, 1992.
24. KEHRER, J. P.: Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23: 21-48, 1993.
25. KYLE, M. E., NAKAE, D., SAKAIDA. L, SERRONI, A. AND FARBER, J. L.: Protein thiol depletion and the killing of cultured hepatocytes by hydrogen peroxide. Biochim. Pharmacol. 38: 3797-3805, 1989.
26. LAUPACIS, A., KEOWN, P. A., ULAN, R. A., SINCLAIR, N. R. AND STILLER, C. R: Hyperbilirubinemia and cyclosporin A levels. Lancet 19: 1426-1427, 1981.
27. 4 intoxication, and vitamin E-deficiency. Biochem. Med. 23: 302-311, 1980.
28. MEISTER, A.: Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51: 155-194, 1991.
29. MENTHA, G. AND HOUSSIN, D.: La ciclosporine: Un immunosuppresseur selectif en hepatogie. Gastroenterol. Clin. Biol. 10: 641-647, 1986.
30. NAKAGAWA, Y., COTGREAVE, I. A. AND MOLDEUS, P.: Relationships between ascorbic acid and α-tocopherol during diquat-induced redox cycling in isolated rat hepatocytes. Biochem. Pharmacol. 42: 883-888, 1991.
31. NAGY, E. AND DEGRELL, I.: Determination of ascorbic acid and dehydroascorbic acid in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection. J. Chromatogr. 497: 276-281, 1989.
32. PACIFICI, R. E. AND DAVIES, K. J. A.: Protein degradation as an index of oxidative stress. Methods Enzymol. 186: 485-502, 1990.
33. PASCOE, G. A. AND REED, D. J.: Cell calcium, vitamin E, and the thiol redox system in cytotoxicity. Free Radical Biol. Med. 6: 209-224, 1989.
34. PATEL, J. M. AND BLOCK, E. R.: The effect of oxidant gases on membrane fluidity and function in pulmonary endothelial cells. Free Radical Biol. Med. 4: 121-134, 1988.
35. PIETRANGELO, A., GRANDI, R., TRIPODI, A., TOMASI, A., CECCARELI, D., VENTRURA, E. AND MASINI, A.: Lipid composition and fluidity of liver mitochondria, microsomes, and plasma membrane of rats with chronic dietary iron overload. Biochem. Pharmacol. 39: 123-128, 1990.
36. PRYOR, W. A.: On the detection of lipid hydroperoxides in biological samples. Free Radical Biol. Med. 7: 177-178, 1989.
37. ROGDER, R. S. C., TURNEY, J. H., HAINES, I., MICHAEL. J., ADU, D. AND MCMASTER, P.: Cyclosporine and liver functions in renal allograft recipients. Transplant. Proc. 15: suppl.1/2: 2754-2756, 1983.
38. ROMAN, I. D., MONTE, M. J., GONZALEZ-BUITRAGO, J. M., ESTELLER, A. AND JIMENEZ, R.: Inhibition of hepatocellular vesicular transport by cyclosporin A in the rat: Relationship with cholestasis and hyperbilirubinemia. Hepatology. 12: 83-91, 1990.
39. SATTERTHWAITE, F. W.: An approximate distribution of estimates of variance components. Biom. Bull. 2: 110-114, 1946.
40. SCHADE, R. R., GUGLIELMI, A., VAN THIEL, D. H., THOMSON, M. E., WARTY, V., GRIFFITH, B., SANGHVI, A., BAHNSON, H. AND HARDESTY, R.: Cholestasis in heart transplant recipients treated cyclosporine. Transplant. Proc. 25: 2757-2760, 1983.
41. SCHEFFE, H.: The Analysis of Variance, John Wiley & Sons. Inc., New York, 1959.
42. SEDLAK, J. AND LINDSAY, R. H.: Estimation of total, protein-bound, and nonprotein sulphydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25: 192-205, 1968.
43. SORESI, M., SPARACION, V., PISCCIOTTA, G., BONFISSUTO, G., CAPUTO, F., CARROCCIO, A., CALABRESE, S. AND MONTALTO, G.: Effects of cyclosporin A on various indices of cholestasis in kidney transplant recipients. Minerva Urol. Nefrol. 47: 65-69, 1995.
44. SIES, H.: Introduction. In Oxidative Stress, ed. by H. Sies, pp. 1-8, Academic Press, London, 1985.
45. SMITH, C. V.: Correlation and apparent contradictions in assessment of oxidant stress status in vivo. Free Radical Biol. Med. 10: 217-224, 1991.
46. SERINO, F., GREVEL, J., NAPOLI, K. L., KAHAN, B. D. AND STROBEL, H. W.: Oxygen radical formation by the cytochrome P450 system as a cellular mechanism of cyclosporine toxicity. Transplant. Proc. 26: 2916-2917, 1994.
47. TIETZE, T.: Enzymatic method for quantificative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues, Anal. Biochem. 27: 502-522, 1969.
48. TYSON, C. A. AND GREEN, C. E.: Cytotoxicity measures: Choice and methods. In The Isolated Hepatocyte, Use in Toxicology and Xenobiotic Biotransformations, ed. by E. J. Rauckmann and G. M. Padilla, pp. 119-158, Academic Press, Orlando, 1987.
49. VANDEPUTTE, C., GUIZON, I., GENESTIE-DENIS, I., VANNIER, B. AND LORENZON, G.: A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: Performance study of a new miniaturized protocol. Cell Biol. Toxicol. 10: 415-421, 1994.
50. 2: Protection of membranes from lipid peroxidation damage. Trends Biochem. Sci. 12: 31-34, 1987.
51. WEDLER, A. A. AND ACOSTA, D.: Membrane Integrity and Function. In Methods in Toxicology, ed. by C. A. Tyson and J. M. Frazier, vol. 1, part B, pp. 46-49, Academic Press, San Diego, 1994.
52. WOLF, A. AND DONATSCH, P.: Cyclosporin A-dependent induction of lipid peroxidation in rat liver and kidney (Abstract). Free Radical Biol. Med. 9: 123, 1990a.
53. WOLF, A., DONATSCH, P. AND RICKENBACHER, U.: Induction of lipid peroxidation by cyclosporin A, a possible mechanism of drug toxicity. In Proceedings of the VIIIth International Symposium on Microsomes and Drug Oxidations, ed. by M. Ingelman-Sundberg, J. A. Gustafsson and S. Orrenius, pp.189, A361, 1990b
54. R) induces the formation of free reactive oxygen species in vitro in rat liver and kidney microsomes. In Oxygen Radicals, ed. by K. Yagi, M. Kondo, E. Niki and T. Yoshikawa, pp. 525-528, Elsevier Science Publishers B. V., Amsterdam, 1992.
55. WOLF, A., TRENDELENBURG, C. F., DIEZ-FERNANDEZ, C., PRIETO, P. AND CORDIER, A.: Role of glutathione in cyclosporin A in vitro hepatotoxicity. Transplant. Proc. 26: 2912-2914. 1994a.
56. WOLF, A., CLEMANN, N., FRIEAUFF, W., RYFFEL, B. AND CORDIER, A.: Role of reactive oxygen formation in the cyclosporine A-mediated impairment of renal functions. Transplant. Proc. 26: 2902-2907, 1994b.
57. YAGI, K.: Assay for blood plasma or serum. Methods Enzymol. 105: 329-331, 1984.